Immuron, Naval Medical Research Center Partner to Test Supplement Against Stomach-Ailing Bacteria
Australia-based Immuron has entered a research and development collaboration agreement with the Naval Medical Research Center to test the bio-pharmaceutical company’s drug against gastrointestinal problems. The company said Aug. 30 it will test the Travelan dietary supplement against Campylobacter and Enterotoxigenic Escherichia coli gram-negative bacteria to help develop therapeutics in an effort to protect military and civilian populations from diarrhea. Immuron and NMRC researchers […] More